SCHEMBL19130511

SCHEMBL19130511

Cc1ccccc1[C@@](C)(O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 1/20 0.47
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
ESR1 P03372 3/20 0.41
ESR2 Q92731 3/20 0.41
ALDH1A1 P00352 4/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP3A4 P08684 2/20 0.40
MAPK1 P28482 1/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 2/20 0.38
ACHE P22303 1/20 0.38
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
MEN1 O00255 2/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848041 1.00 CASR (0.47) CASRGABRA1GABRB2ESR1ESR2
SCHEMBL11336791 0.88 CASR (0.45) CASRGABRA1GABRB2ESR1ESR2
SCHEMBL874172 0.86 CASR (0.53) CASRGABRA1GABRB2ALDH1A1TSHR
Ammonia Solution, Strong SCHEMBL27910256 0.84 TRPA1 (0.42) CASRGABRA1GABRB2ESR1ESR2
SCHEMBL2387148 0.81 GABRA1 (0.43) CASRGABRA1GABRB2ESR1ESR2
SCHEMBL11475054 0.80 KMT2A (0.50) CASRGABRA1GABRB2ESR1ESR2
SCHEMBL7011213 0.80 ALDH1A1 (0.60) ESR1ESR2ALDH1A1ALOX15TSHR
SCHEMBL7030617 0.80 CYP3A4 (0.44) CASRGABRA1GABRB2ESR1ESR2
SCHEMBL813137 0.80 CRHBP (0.55) CASRGABRA1GABRB2ESR1ESR2
SCHEMBL7120000 0.78 CYP2C19 (0.47) ESR1ESR2ALDH1A1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines UNIVERSITY COLLEGE DUBLIN (IE) 2019-02-05 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines ADH1C, ADH1A, ADH5 CASR 4700/4885GABRA1 1468/4885GABRB2 1337/4885
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES ADH1C, ADH1A, ADH5 CASR 4690/4885GABRA1 1569/4885GABRB2 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.